Literature DB >> 29803381

T1 mapping on gadoxetic acid-enhanced MR imaging predicts recurrence of hepatocellular carcinoma after hepatectomy.

Wen-Tao Wang1, Shuo Zhu1, Ying Ding1, Li Yang1, Cai-Zhong Chen1, Qing-Hai Ye2, Yuan Ji3, Meng-Su Zeng1, Sheng-Xiang Rao4.   

Abstract

PURPOSE: Our purpose was to demonstrate the prognostic significance of T1 mapping on gadoxetic acid-enhanced MR imaging in prediction of recurrence of single HCC after hepatectomy.
MATERIALS AND METHODS: One hundred and seven patients with single nodular HCC (≤3 cm) who underwent preoperative gadoxetic acid-enhanced MRI were included in the study. T1 mapping with syngo MapIt was obtained on a 1.5 T scanner. Radiological features and reduction rate of T1 relaxation time (Δ%) of tumors were assessed by two radiologists. Cumulative recurrence rates were compared between groups of low and high reduction rate of T1 relaxation time. A further classified cumulative recurrence rate of the overall cohort was based on the numbers of independent predictive factors.
RESULTS: Reduction rate of T1 relaxation time (P = 0.001) and non-hypervascular hypointense nodules (P = 0.042) in preoperative gadoxetic acid-enhanced MRI were independently related to recurrence of HCC after hepatectomy. Patients of lower reduction rates group had higher cumulative recurrence rates (P < 0.0001) than patients of higher reduction rates group. A combination of the two risk factors in patients with single HCC had significantly higher recurrence rates compared to those with either or none of the two risk factors.
CONCLUSIONS: Reduction rate of T1 relaxation time combined with non-hypervascular hypointense nodules can be reliable biomarkers in the preoperative prediction of recurrence of HCC after hepatectomy.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hepatectomy; Hepatocellular carcinoma; Magnetic resonance imaging; Recurrence; T(1) mapping

Mesh:

Substances:

Year:  2018        PMID: 29803381     DOI: 10.1016/j.ejrad.2018.03.027

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  7 in total

1.  Prediction of early recurrence of hepatocellular carcinoma after resection based on Gd-EOB-DTPA enhanced magnetic resonance imaging: a preliminary study.

Authors:  Qi-Yu Zhao; Shi-Shun Liu; Ming-Xin Fan
Journal:  J Gastrointest Oncol       Date:  2022-04

2.  Contrast-enhanced ultrasound-based ultrasomics score: a potential biomarker for predicting early recurrence of hepatocellular carcinoma after resection or ablation.

Authors:  Hui Huang; Si-Min Ruan; Meng-Fei Xian; Ming-de Li; Mei-Qing Cheng; Wei Li; Yang Huang; Xiao-Yan Xie; Ming-de Lu; Ming Kuang; Wei Wang; Hang-Tong Hu; Li-Da Chen
Journal:  Br J Radiol       Date:  2021-11-29       Impact factor: 3.039

3.  Newly detected liver nodules with a history of colorectal cancer: are they metastatic? Review of 2,632 cases in a single center.

Authors:  Kai Zhu; Wentao Wang; Rongkui Luo; Danjun Song; Xi Wang; Qiang Gao; Jia Fan; Jian Zhou; Shengxiang Rao; Xiaoying Wang
Journal:  Ann Transl Med       Date:  2021-07

Review 4.  Updates on Imaging of Liver Tumors.

Authors:  Arya Haj-Mirzaian; Ana Kadivar; Ihab R Kamel; Atif Zaheer
Journal:  Curr Oncol Rep       Date:  2020-04-16       Impact factor: 5.075

5.  Hepatocellular carcinoma grading and recurrence prediction using T1 mapping on gadolinium-ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging.

Authors:  Xiali Qin; Tengfei Yang; Zhongkui Huang; Liling Long; Zhipeng Zhou; Wenmei Li; Yinjuan Gao; Mengzhu Wang; Xiaoyong Zhang
Journal:  Oncol Lett       Date:  2019-07-04       Impact factor: 2.967

6.  Value of T1 mapping on gadoxetic acid-enhanced MRI for microvascular invasion of hepatocellular carcinoma: a retrospective study.

Authors:  Chenyi Rao; Xinquan Wang; Minda Li; Guofeng Zhou; Hongmei Gu
Journal:  BMC Med Imaging       Date:  2020-04-28       Impact factor: 1.930

7.  Pre-radiofrequency ablation MRI imaging features predict the local tumor progression in hepatocellular carcinoma.

Authors:  Zhouchao Hu; Nannan Yu; Heping Wang; Shibo Li; Jingang Yan; Guoqiang Zhang
Journal:  Medicine (Baltimore)       Date:  2020-12-24       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.